OrangeKloud Technology Receives Nasdaq Delisting Notice; Appeals Decision
Summary
OrangeKloud Technology Inc. has received a Nasdaq delisting notice due to non-compliance with the minimum bid price rule, a recurring issue for the company. The company plans to appeal the determination, which will temporarily stay the delisting process.
Key Events
-
Nasdaq Delisting Notice Received
On January 29, 2026, OrangeKloud Technology Inc. received a Staff Delisting Determination from Nasdaq for failing to maintain a minimum bid price of $1.00 per share, violating Listing Rule 5550(a)(2).
-
Ineligible for Grace Period
The company is not eligible for the standard 180-day grace period to regain compliance, as it previously cured a minimum bid price deficiency via a reverse stock split within the last twelve months.
-
Company Appeals Determination
OrangeKloud intends to appeal the delisting determination to the Nasdaq Hearings Panel, which will stay the suspension of trading or delisting pending the hearing and the Panel's decision.
Analysis
This delisting notice is a critical event for OrangeKloud Technology, a micro-cap company, as continued listing on Nasdaq is vital for liquidity and investor confidence. The situation is particularly severe because the company is ineligible for the standard grace period, having already used a reverse stock split to address a prior minimum bid price deficiency within the last year. While the appeal process will temporarily halt delisting, there is no guarantee the Nasdaq Hearings Panel will approve the company's compliance plan. Failure to regain compliance could result in the stock moving to OTC markets, significantly impacting its tradability and potentially leading to substantial value erosion for shareholders. Investors should closely monitor the outcome of the appeal and the company's strategy to meet Nasdaq's requirements.
At the time of this filing, ORKT was trading at $1.20 on NASDAQ in the Technology sector, with a market capitalization of approximately $20.5M. The 52-week trading range was $0.62 to $7.60. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.